Evidence map›Paper›PMID 40212223›Full record

ArticleAnnals of medicine and surgery (2012)2025

A case of familial hypertriglyceridemia associated with a novel heterozygous AGPAT2 mutation.

Nasser M AbuDujain, Yazeed Alekrish, Ebtihal Y Alyusuf, Ibrahim Alsadhan, Saleh Albanyan, Turky H Almigbal, Aishah Ekhzaimy, Mohamed Almaatouq

Abstract readCase Reports
In one paragraph

Article in Annals of medicine and surgery (2012), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Nasser M AbuDujainUniversity Family Medicine Center, Department of Family and Community Medicine, King Saud University Medical City, Riyadh, Saudi Arabia.
Yazeed AlekrishDepartment of Medicine, College of Medicine, King Saud University, Riyadh, Saudi Arabia.
Ebtihal Y AlyusufDivision of Endocrinology, Department of Internal Medicine, Salmanyia Medical Complex, Manama, Bahrain.
Ibrahim AlsadhanDivision of Endocrinology, Department of Internal Medicine, King Saud University Medical City, Riyadh, Saudi Arabia.
Saleh AlbanyanDepartment of Medicine, College of Medicine, King Saud University Medical City, King Saud University, Riyadh, Saudi Arabia.
Turky H AlmigbalUniversity Family Medicine Center, Department of Family and Community Medicine, King Saud University Medical City, Riyadh, Saudi Arabia.
Aishah EkhzaimyDivision of Endocrinology, Department of Internal Medicine, King Saud University Medical City, Riyadh, Saudi Arabia.
Mohamed AlmaatouqDepartment of Medicine, College of Medicine, King Saud University Medical City, King Saud University, Riyadh, Saudi Arabia.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Introduction and importance: Severe hypertriglyceridemia is increasingly leading to referrals to endocrinology clinics. Patients commonly present with clinical manifestations such as recurrent abdominal pain, acute pancreatitis, and eruptive xanthomas. Case presentation: We report the case of a young male patient with over 30 recurrent episodes of acute pancreatitis and extremely elevated triglyceride levels. Genetic testing identified a heterozygous pathogenic mutation in the 1-acylglycerol-3-phosphate-o-acetyltransferase 2 (AGPAT2) gene. Further deletion/duplication analysis of the AGPAT2 gene was negative. The clinical presentation closely resembled type I hyperlipoproteinemia. Clinical discussion: Despite the typical presentation of type I hyperlipoproteinemia, the identification of a heterozygous AGPAT2 mutation suggests a potential novel genetic contributor to familial hypertriglyceridemia. This finding highlights the importance of genetic analysis in understanding atypical presentations of hyperlipoproteinemia and underscores the need to explore this mutation's inheritance patterns and pathophysiological implications. Conclusion: The heterozygous AGPAT2 mutation may represent a novel genetic factor in familial hypertriglyceridemia. Further research is needed to clarify its clinical significance and inheritance mechanisms.

Indexed as

AGPAT2dyslipidemiapancreatitis

Identifiers

PMID40212223
PMCPMC11981449

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-SA
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.